본문 바로가기
KERD
논문KCI 등재

Validation of the Korean Version of the Patient-Reported Outcomes Measurement Information System 29 Profile V2.1 among Cancer Survivors

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile v2.1 (K-PROMIS-29 V2.1) among cancer survivors. Materials and methods: Participants were recruited from outpatient clinics of the Comprehensive Cancer Center at the Samsung Medical Center in Seoul, South Korea, from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30). Principal component analysis and confirmatory factor analysis (CFA) and Pearson's correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1. Results: The mean age of the study participants was 54.4 years, the mean time since diagnosis was 1.2 (±2.4) years, and 349 (87.3%) completed the entire questionnaire. The Cronbach's alpha coefficients of the seven domains in the K-PROMIS-29 V2.1 ranged from 0.81 to 0.96, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the K-PROMIS-29 V2.1 were high (comparative fit index, 0.91 and standardized root-mean-squared residual, 0.06). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the EORTC QLQ-C30 (r=0.52-0.73). Conclusion: The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing the health-related quality of life domains in a cancer population, thus supporting their use in studies and oncology trials.

Abstract

Purpose: The purpose of the study was to validate the Korean version of Patient-Reported Outcomes Measurement Information System 29 Profile v2.1 (K-PROMIS-29 V2.1) among cancer survivors. Materials and methods: Participants were recruited from outpatient clinics of the Comprehensive Cancer Center at the Samsung Medical Center in Seoul, South Korea, from September to October 2018. Participants completed a survey questionnaire that included the K-PROMIS-29 V2.1 and the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30). Principal component analysis and confirmatory factor analysis (CFA) and Pearson's correlations were used to evaluate the reliability and validity of the K-PROMIS-29 V2.1. Results: The mean age of the study participants was 54.4 years, the mean time since diagnosis was 1.2 (±2.4) years, and 349 (87.3%) completed the entire questionnaire. The Cronbach's alpha coefficients of the seven domains in the K-PROMIS-29 V2.1 ranged from 0.81 to 0.96, indicating satisfactory internal consistency. In the CFA, the goodness-of-fit indices for the K-PROMIS-29 V2.1 were high (comparative fit index, 0.91 and standardized root-mean-squared residual, 0.06). High to moderate correlations were found between comparable subscales of the K-PROMIS-29 V2.1 and subscales of the EORTC QLQ-C30 (r=0.52-0.73). Conclusion: The K-PROMIS-29 V2.1 is a reliable and valid measure for assessing the health-related quality of life domains in a cancer population, thus supporting their use in studies and oncology trials.

참고문헌 (30)

  1. 김주영, "Choosing Wisely: The Korean Perspective and Launch of the ‘Right Decision in Cancer Care’ Initiative", Cancer Research and Treatment, 52(3), pp.655~660 (2020), 대한암학회[DOI]
  2. European Medicines Agency, "Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: the use of patient–reported outcome (PRO) measures in oncology studies", European Medicines Agency, ~ (2016)
  3. Aaronson NK, "The European Organization for Research and Treatment of Cancer QLQ-C30 : a quality-of-life instrument for use in international clinical trials in oncology", J Natl Cancer Inst, 85, pp.365~376 (1993)
  4. Cella DF, "The Functional Assessment of Cancer Therapy scale : development and validation of the general measure", J Clin Oncol, 11, pp.570~579 (1993)
  5. Sprangers MA, "The European Organization for Research and Treatment of Cancer: approach to quality of life assessment: guidelines for developing questionnaire modules. EORTC Study Group on Quality of Life", Qual Life Res, 2, pp.287~295 (1993)
  6. Jensen RE, "United States population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer", J Clin Oncol, 35, pp.1913~1920 (2017)
  7. Brenner H, "Long-term survival rates of cancer patients achieved by the end of the 20th century : a period analysis", Lancet, 360, pp.1131~1135 (2002)
  8. Grande GE, "Quality of life measures(EORTC QLQ-C30 and SF-36)as predictors of survival in palliative colorectal and lung cancer patients", Palliat Support Care, 7, pp.289~297 (2009)
  9. Ware JE Jr, "The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection", Med Care, 30, pp.473~483 (1992)
  10. Brooks R, "EuroQol : the current state of play", Health Policy, 37, pp.53~72 (1996)
  11. Wells GA, "Validity of quality of life measurement tools : from generic to disease-specific", J Rheumatol Suppl, 88, pp.2~6 (2011)
  12. Efthymiadou O, "Health related quality of life aspects not captured by EQ-5D-5L : results from an international survey of patients", Health Policy, 123, pp.159~165 (2019)
  13. Cella D, "The Patient-Reported Outcomes Measurement Information System(PROMIS)developed and tested its first wave of adult self-reported health outcome item banks : 2005-2008", J Clin Epidemiol, 63, pp.1179~1194 (2010)
  14. Jensen RE, "Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients", Qual Life Res, 24, pp.2333~2344 (2015)
  15. Quach CW, "Reliability and validity of PROMIS measures administered by telephone interview in a longitudinal localized prostate cancer study", Qual Life Res, 25, pp.2811~2823 (2016)
  16. Fayers PM, "The EORTC QLQ-C30 scoring manual" (2001), European Organization for Research and Treatment of Cancer
  17. Yun YH, "Validation of the Korean version of the EORTC QLQ-C30", Qual Life Res, 13, pp.863~868 (2004)
  18. Ursachi G, "How reliable are measurement scales? External factors with indirect influence on reliability estimators", Procedia Econ Financ, 20, pp.679~686 (2015)
  19. Hu LT, "Cutoffcriteria for fit indexes in covariance structure analysis : conventional criteria versus new alternatives", Struct Equ Modeling, 6, pp.1~55 (1999)
  20. Mokkink LB, "The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments : an international Delphi study", Qual Life Res, 19, pp.539~549 (2010)
  21. Hinkle DE, "Applied statistics for the behavioral sciences" (2003), Houghton Mifflin
  22. van Kooten JA, "Content validity of the patient-reported outcomes measurement information system sleep disturbance and sleep related impairment item banks in adolescents", Health Qual Life Outcomes, 14, pp.92~ (2016)
  23. Terwee CB, "Quality criteria were proposed for measurement properties of health status questionnaires", J Clin Epidemiol, 60, pp.34~42 (2007)
  24. Dobson KS, "The relationship between anxiety and depression", Clin Psychol Rev, 5, pp.307~324 (1985)
  25. Krueger RF, "Using item response theory to understand comorbidity among anxiety and unipolar mood disorders", Psychol Assess, 13, pp.140~151 (2001)
  26. Libman E, "Refreshing sleep and sleep continuity determine perceived sleep quality", Sleep Disord, 2016, pp.7170610~ (2016)
  27. Hartman JD, "Comparing and transforming PROMIS utility values to the EQ-5D", Qual Life Res, 27, pp.725~733 (2018)
  28. Morrisroe K, "Validity of the workers productivity and activity impairment questionnaire : specific health problem(WPAI : SHP)in patients with systemic sclerosis", Clin Exp Rheumatol, 35(Suppl 106), pp.130~137 (2017)
  29. HinchcliffME, "Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis", J Rheumatol, 42, pp.64~72 (2015)
  30. Forrest CB, "Commentary : the patient-reported outcome measurement information system(PROMIS(R))for children and youth : application to pediatric psychology", J Pediatr Psychol, 37, pp.614~621 (2012)

관련 논문AI추천

Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in Lymphoma Survivors강단비, 김석진, 김원석, 김임령, 조주희, Betty Ferrell대한암학회 · Cancer Research and Treatment2018 · 제50권 제1호Psychometric Validation of the Korean Version of the Cancer Survivors’ Unmet Needs (CaSUN) Scale among Korean Non–Small Cell Lung Cancer Survivors강단비, 공성아, 김수연, 김홍관, 남희수, 신동욱, 신수민, 심성근, 심영목, 이재경, 이진희, 정원영, 조재일, 조주희대한암학회 · Cancer Research and Treatment2023 · 제55권 제1호Multidimensional Constructs of the EORTC Quality of Life Questionnaire (QLQ-C30) in Korean Cancer Patients with Heterogeneous Diagnoses왕희정, 이은현, 전미선, 최진혁, Ho Yeong Lim대한암학회 · Cancer Research and Treatment2005 · 제37권 제3호Exploring the Latent Trait and the Measurement Properties of Korean World Health Organization Quality of Life-BREF Measure Applied to Cancer Survivorschoi bongsam한국전문물리치료학회 · 한국전문물리치료학회지2023 · 제30권 제2호Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors강단비, 김나연, 김석원, 김현수, 남석진, 박정현, 심성근, 유재민, 유종한, 이만경, 이세경, 이정언, 임지현, 조주희, 채병주, 한가연대한암학회 · Cancer Research and Treatment2022 · 제54권 제3호Development and Feasibility Evaluation of Smart Cancer Care 2.0 Based on Patient-Reported Outcomes for Post-Discharge Management of Patients with Cancer강동윤, 고수진, 권은지, 권진아, 김진성, 노영주, 서정욱, 양솔빈, 양송수, 옥민수대한암학회 · Cancer Research and Treatment2024 · 제56권 제4호

이 간행물의 다른 논문 (29건)

Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group김효송, 천재경, 임선민, 윤지나, 장대영, 차용준, 강진형, 박인근, 이인희, 김한상, 홍용상, 장세진, 윤홍석, 안희경, 윤신교, 김태원, 유창훈, 김인호, 김지현, 김진원, 김지훈, 김승태, 김미소, 정재호pp. 1-9Analysis of Cancer Patient Decision-Making and Health Service Utilization after Enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea김달용, Dae Seog Heo, 임채만, 유신혜, 신성준, 김도연, Min Sun Kim, 이현정, 서세영, 임지연pp. 20-29Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations신상원, 임승택, 장원진, 박경화, 이종원, 강은주, 조성심, 김정선, 임태규, 김혜숙, 김유정, 이수현, 최정윤, 김주원, 조장호, 안미선, 임아름, 김영생, 박지현, 이영우, 정희준, 김열홍, 최윤지, 성재숙pp. 30-39Targeted Liquid Biopsy Using Irradiation to Facilitate the Release of Cell-Free DNA from a Spatially Aimed Tumor Tissue박지현, 안원균, 노재명, 표홍렬, 박웅양, 이호연, 김연정, 최창훈, 이태섭, 박동현pp. 40-53Increased Radiosensitivity of Solid Tumors Harboring ATM and BRCA1/2 Mutations이준복, 김한상, 윤홍인, 장지석, 양지훈, 김경환, 안중배, 심효섭, 김승섭pp. 54-64